Correction. In the article "Cytolysis by tumor necrosis factor is preceded by a rapid and specific dissolution of microfilaments" by Mary Scanlon, Scott M. Laster, John G. Wood, and Linda R. Gooding, which appeared in number 1, January 1989, of Proc. Natl. Acad. Sci. USA (86, 182-186), Fig. 5 was poorly reproduced due to a printer's error. Correction. In the article "Detection of two growth hormone receptor mRNAs and primary translation products in the mouse," by William C. Smith (1) and in the concentration of GHR polypeptides during gestation (3) . and the growth hormone receptor primary translation products were identified by immunoprecipitation with anti-mouse growth hormone receptor antiserum followed by sodium dodecyl sulfate/PAGE and fluorography. Detectable amounts of the Mr 95,900 and 31,800 proteins were not present in in vitro-translated nonpregnant mouse liver mRNA. This result is consistent with previous observations of the up-regulation of growth hormone receptors in the liver during pregnancy in the mouse. Northern (RNA) blot analysis of mouse liver and adipose tissue RNA with a rabbit growth hormone receptor cDNA probe revealed two hybridizing mRNAs of =3.9 and 1.2 kilobases. These two RNAs were greatly up-regulated in liver, but not in adipose tissue, during pregnancy. The sizes of these mRNAs closely matched predictions of the sizes of the mRNAs codingfor the proteins ofMr 95,90 and 31,800 made by in vitro translation of size-fractionated late-pregnant mouse liver poly(A)PRNA. These results suggest a mechanism for the generation of both the heterogeneous forms of the growth hormone receptor identified in mouse liver membrane preparations and the mouse serum growth hormone-binding protein.
The 8-to 10-fold increase in specific growth hormone (GH) binding to the liver during pregnancy in the mouse (1) has provided a useful model for characterizing growth hormone receptor (GHR) structure. Affinity cross-linking studies (2) have shown that the GHR is present in 17-day pregnant mouse liver microsomal membranes in three forms with cross-linked Mr values of 125,000, 62,000, and 56,000, corresponding to receptor sizes of approximate Mr 103,000, 39,000, and 33,000. Subsequently, the three forms of the hepatic GHR were shown to be closely related structurally and were perhaps derived from a common precursor (2, 3) . The significance and the origin of these three related GHR species in the mouse liver have not been determined'. However, recent results from our laboratory have shown that the previously characterized, pregnancy-specific, serum GHbinding protein (4) is similar in Mr and immunological properties to the low Mr forms of the GH receptor found in the mouse liver (5) .
The recent cloning and sequencing of the rabbit and human GH receptor cDNAs (6) has provided a wealth of information on the GH receptor. These cDNAs also provide an important tool for the study of the heterogeneous forms of the mouse GHR. In this report we describe the characterization of GHR-encoding mRNAs in mouse liver and adipose tissue RNA preparations using the rabbit GHR cDNA clone as a hybridization probe in Northern RNA Isolation. Tissues were collected from virgin female and 17-day pregnant Swiss-Webster mice and frozen immediately in dry ice/ethanol. RNA was isolated as described previously (7). Briefly, the tissue was homogenized in guanidinium thiocyanate solution using a Brinkmann Polytron homogenizer (8) . The homogenate was layered onto a cesium chloride cushion and centrifuged in a Beckman SW41 rotor at 33,000 rpm for 25 hr (9) . The pelleted RNAs were extracted with phenol/chloroform, ethanol precipitated, and solubilized in water.
In Vitro Translation and Immunoprecipitation. Ten micrograms ofthe isolated RNAs were translated'for 90 min at 30'C in a total volume of 30 jul of a rabbit reticulocyte lysate in vitro-translation system containing 10 1ul lysate, 15 uCi of L-[35S]methionine, and methionine-free translation mixture provided by the manufacturer. Three-microliter aliquots of the reaction mixtures were then taken to determine incorporation of the label by trichloroacetic acid precipitation. The remainder of the samples were immunoprecipitated with anti-mouse growth hormone receptor (camGHR) antiserum essentially as described in Smith et al. (3) . Sodium dodecyl sulfate (SDS) was added to the samples to a final concentration of 1%, and the samples were then heated to 100'C for 5 min. The samples were diluted with 4 vol of 1.25% (wt/vol) Triton X-100/100 mM Tris HCI, pH 7.4/150 mM NaCl. Fifty microliters of a 10% suspension of Pansorbin immunoabsorbant were then added to the samples. polyvinylpyrrolidone/0.02% bovine serum albumin)/5 x SSPE (lx SSPE = 0.18 M NaCI/10 mM sodium phosphate, pH 7.7/1 mM EDTA)/0.1% SDS containing denatured salmon sperm DNA at 100 ,ug/ml. The filter was then incubated in the above solution with the addition of 50% formamide for 12 hr at 37°C with a rabbit GHR 32P-labeled cDNA probe at 1 x 106 dpm/ml (specific activity, -3 x 109 dpm/,ug) prepared as follows. A 638-base-pair rabbit GHR cDNA fragment encoding amino acid residues 105-318 of the rabbit GHR (6) was released from the plasmid pUC118 by digestion with EcoRI and BamHI, isolated by agarose/gel electrophoresis, and used as a template for random-sequence hexanucleotide priming by the method of Feinberg and Vogelstein (14) . After incubation with the rabbit GHR cDNA probe, the filter was washed two times for 30 and 31,800, as revealed by fluorography of samples electrophoresed on 10% polyacrylamide gels (Fig. 1) . These two proteins were not present in samples in which nonimmune rabbit serum was used in place of amGHR antiserum, nor could these two proteins be identified in the immunoprecipitates of in vitro-translated virgin female mouse liver RNA (Fig. 1) .
To determine whether the 95,900 and the 31,800 Mr polypeptides were derived from independent mRNAs, pregnant mouse liver poly(A)+ RNA was fractionated on a methyl mercury/agarose gel, and the size-fractionated RNAs were translated in vitro. As seen in Fig. 2 Fig. 2 similar, although less intense, band was also identified in Fig.  1 , both in samples in which amGHR antiserum and nonimmune rabbit serum was used. The nature of this band was not clear, although its presence in all fractions shown in Fig. 2 suggested that it might be a product of endogenous reticulocyte RNA in the lysate. Recently, the mRNAs for the rabbit and the human GHR have been isolated as cDNA clones (6) . Hybridization of this rabbit GHR cDNA to mouse liver RNA revealed two RNA species of 3.9 and 1.2 kb (Fig. 3) , consistent with the sizes of the mouse GHR mRNAs predicted from the in vitro translation data. Thus, a mouse GHR mRNA of 3.9 kb appears to be translated into a Mr 95,900 polypeptide precursor, whereas a 1.2-kb mRNA encodes a Mr 31,800 polypeptide product. Both of these mRNAs are enriched in day-17 pregnant compared with nonpregnant female mouse liver. Thus, the pregnancy-related increase in mouse liver GHR levels appears to be due to a corresponding increase in the concentration of mouse GHR mRNA in this tissue during gestation.
DISCUSSION
Several lines of evidence strongly indicate that the Mr 95,900 and 31,800 proteins immunoprecipitated from in vitrotranslated late-pregnant mouse liver RNA are the mouse GHR mRNA primary translation products. The specificity of the amGHR antiserum has been previously demonstrated by immunostaining of Western (immunologic) blotted mouse liver microsomal membrane protein (3). The absence of detectable amounts of the Mr 95,900 and 31,800 proteins in the immunoprecipitates of in vitro-translated virgin female mouse liver RNA (Fig. 1) is consistent with our previous observation of the absence of detectable amounts of immunostaining mouse GHRs in Western blots (immunoblots) of nonpregnant mouse liver membranes (3) and is presumed to Ten-microgram samples of liver and adipose tissue total cellular RNA from both 17-day pregnant and nonpregnant mice were electrophoresed on formaldehyde/agarose gels, transferred to a Nytran membrane, and hybridized with a rabbit GHR cDNA probe prepared by random-sequence hexanucleotide priming.
reflect the well-characterized up-regulation of liver GHRs in the mouse during pregnancy (1) . In addition, the observed sizes of the mouse putative GHR primary translation products match very closely the deglycosylated Mr values of the GHR observed in mouse liver membrane preparations. Cleavage of N-linked carbohydrate residues from the two isolated low Mr forms of the mouse GHR (Mr = 40,700 and 37,500) with peptide N-glycosidase F (glycopeptide glycanohydrolase) reduced their Mr values to 33,600 and 30,900, respectively (3) . It has been shown by deglycosylation of cross-linked mouse GHRs that the high M, form of the GHR has a similar degree of glycosylation as the low Mr forms (2) and has a predicted deglycosylated Mr of =95,000. The small differences in the Mr values of the deglycosylated mouse GHRs and the primary translation products might reflect the presence of a signal peptide on the latter.
Due to reports of the susceptibility of GHRs to proteolytic degradation (6, 16) , it was essential to demonstrate that the mouse Mr 31,800 GHR primary translation product did not arise by degradation of the Mr 95,900 polypeptide. As shown in Fig. 2 , the mRNAs encoding the two mGHR primary translation products can be separated by fractionation on agarose gels, indicating that the lower Mr GHR primary translation product does not arise posttranslationally. The fractionation of the pregnant mouse liver poly(A)+ RNA also allowed us to estimate the sizes of the mRNAs encoding the two mouse GHR primary translation products as =-3.1-4.5 kb and <1.2 kb for the Mr 95,900 and 31,800 M, proteins, respectively.
Sixteen of the N-terminal 17 amino acids of the two low Mr forms of the purified mouse liver GHR have been sequenced (3) and found to have significant homology in the region ofthe 7th to 23rd residues of the recently deduced amino acid sequence for the cloned human and rabbit GHRs (6) [41% and 52% amino acid identity, respectively; 53% and 71% when conservative amino acids changes are included (the rabbit and the human have 53% amino acid identity in this region; 65% when conservative amino acids changes are included)]. This indicates that the GHR identified by us in mouse liver and to which our antiserum was raised is the mouse homolog of the cloned human and rabbit GHRs. A fragment of the rabbit GHR cDNA clone was used to identify mouse GHRencoding mRNAs. The results of Northern blot analysis with the rabbit GHR cDNA probe are consistent with our results, indicating that two GHR-encoding mRNAs are present in mouse liver. The fact that the two RNAs shown to hybridize to the rabbit GHR cDNA probe are both up-regulated during pregnancy in the liver and have sizes approximately those predicated by the in vitro-translation results, strongly suggest that the 3.9-and 1.2-kb RNAs are mouse GHR-encoding mRNAs. The in vitro translation data suggest that the 3.9-kb mRNA encodes the Mr 95,900 polypeptide, whereas the 1.2-kb mRNA encodes the Mr 31,800 form of the mouse during pregnancy is sufficient to account for the increase in GH-binding activity (1) and in the concentration of GHR polypeptides during gestation (3) . These two RNAs could also be identified in samples of RNA isolated from adipose tissue, a tissue with a well-characterized response to GH (17) . No pregnancy-related changes in the levels of these mRNAs could be detected in adipose tissue. Thus, regulation of mouse GHR levels is not identical in all responding tissues. The tissue-specific control of receptor levels may be important for the distinct physiological responses to GH displayed by these different tissue and cell types.
We have previously presented data showing that three forms of the GHR with approximate Mr values of 102,000, 39,000, and 33,000 are present in mouse liver membrane fractions (2) . Our present data indicate that two mRNAs are present in mouse, encoding one high and one low Mr GHR. Coupled with the fact that the two low Mr species observed previously share identical N-terminal amino acid sequences (3), this result suggests that the 1.2-kb mRNA encodes a GHR precursor polypeptide that is posttranslationally modified to give two mature receptor species. The relationship between the 1.2-and 3.9-kb RNAs is at present unclear. It is possible that these mRNAs derive from a single GHR gene by alternative splicing of the primary transcript or, alternatively, they represent transcripts from distinct genes. These results suggest that the heterogenous forms of the GHR identified in mouse liver membrane preparations may arise pretranslationally.
The results of the Northern blot analysis of mouse liver and adipose tissue RNA differ from those presented previously for rabbit liver poly(A)+ RNA. Leung et al. (6) identified a single hybridizing RNA of -4.7 kb using a full-length rabbit GHR cDNA probe. We report here identifying two hybridizing RNAs of =3.9 and 1.2 kb using as a probe a fragment of the rabbit GHR cDNA. These differences might simply reflect a species difference between mice and rabbits; however, the presence or absence of the multiple mRNA species might also be a reflection of the particular physiological state of the animal from which the RNA was isolated. Leung et al. (6) also reported the isolation of two rabbit GHR cDNAs containing stop codons slightly downstream from the putative transmembrane encoding region. It was speculated that the mRNAs corresponding to these cDNAs might encode a serum GH-binding protein (6) . Our present data suggest a different mechanism for the generation of the serum GHbinding protein. The similar size and immunoreactivity of the predominant form of the serum GH-binding protein and the low Mr forms of the liver GHR suggest that they may be identical (5) . It is therefore possible that the serum GHbinding protein is synthesized in the liver, or other tissues, from the 1.2-kb GHR-encoding mRNA, as has been speculated for the low Mr forms of the receptor found in the liver.
